Imuran-induced regression of plasma cell tumor MOPC-315.
D000818:Animals; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001798:Blood Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D009194:Myeloma Proteins / Q000378:metabolism; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000097:blood / Q000188:drug therapy; D010954:Plasmacytoma / Q000097:blood / Q000188:drug therapy*; D014184:Transplantation, Homologous
D001798:Blood Proteins; D007166:Immunosuppressive Agents; D009194:Myeloma Proteins; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine